Article Information
History
- November 16, 2023.
Article Versions
- Version 1 (March 1, 2023 - 10:06).
- Version 2 (March 2, 2023 - 12:12).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Philippe C.G. Adam1,2,3,
- Eline L.M. Op de Coul4,
- Paul Zantkuijl5,
- Maria Xiridou4,
- Hanna Bos5,
- Cor Blom5,
- Itsada Ketsuwan3,
- Margreet J.M. te Wierik4,
- Silke David4 and
- John B.F. de Wit6,*
- 1Centre for Social Research in Health, UNSW Sydney, Sydney, Australia
- 2Institute for Prevention and Social Research (IPSR Utrecht), Utrecht, the Netherlands
- 3IPSR Bangkok, Bangkok, Thailand
- 4National Institute for Public Health and the Environment, Bilthoven, the Netherlands
- 5Soa Aids Nederland, Amsterdam, the Netherlands
- 6Utrecht University, Department of Interdisciplinary Social Science, Utrecht, the Netherlands
- ↵*Correspondence
: John B.F. de Wit, j.dewit{at}uu.nl.
Posted November 16, 2023.
An assessment of rates and covariates of mpox diagnosis and vaccination provides evidence to refine eligibility criteria for mpox vaccination among gay, bisexual and other men who have sex with men in the Netherlands
